NCT03966586

Brief Summary

The investigators will assess the feasibility and acceptability of a pilot intervention to keep people living with HIV (PLHIV) in southern India in care and virologically suppressed. The lack of understanding of the causes of loss from the HIV care continuum in India stifles the armamentarium of effective interventions to keep Indian PLHIV in care. The results of this research will demonstrate the feasibility and acceptability of a pilot intervention targeting the multiple mechanisms by which PLHIV become lost to care. By targeting these mechanisms, this intervention will be designed to be scalable in a setting where access to mental health specialists is limited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable hiv-infections

Timeline
Completed

Started Jun 2019

Longer than P75 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 29, 2019

Completed
22 days until next milestone

Study Start

First participant enrolled

June 20, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

February 12, 2025

Status Verified

July 1, 2022

Enrollment Period

2.4 years

First QC Date

May 24, 2019

Last Update Submit

February 10, 2025

Conditions

Keywords

hivIndiaretentioncontinuum

Outcome Measures

Primary Outcomes (2)

  • Feasibility as assessed by semi-structured qualitative interviews

    Minimal negative impact on clinical work flow and ability to deliver all intervention components, particularly all sessions of enhanced counseling, as measured by semi-structured qualitative interviews of providers

    12 months

  • Acceptability among participants and providers as assessed by semi-structured qualitative interviews

    Acceptability among patients and providers as measured by semi-structured qualitative interviews of participants and providers

    12 months

Secondary Outcomes (8)

  • Retention in care

    12 months

  • Viral suppression (Undetectable HIV-1 RNA, <50 copies / mL)

    3 months

  • ART initiation success (accepted ART and continued ART for at least 6 months)

    6 months

  • Depressive symptoms as measured by PHQ-9

    12 months

  • Internalized stigma as measured by Internalized AIDS-Related Stigma Scale

    12 months

  • +3 more secondary outcomes

Study Arms (2)

Enhanced Care

EXPERIMENTAL

Usual clinical care + intervention components

Behavioral: Active outreachBehavioral: AppointmentsBehavioral: Financial supportBehavioral: MicroenterpriseBehavioral: Enhanced counseling

Usual Care

ACTIVE COMPARATOR

Usual clinical care and counseling

Behavioral: Usual clinical care and counseling

Interventions

Active outreachBEHAVIORAL

Participants will get bidirectional weekly SMS messaging / automated voice messaging (depending on literacy), with messages to be programmed by the participant in the enhanced counseling sessions.

Enhanced Care
AppointmentsBEHAVIORAL

Participants in the enhanced-care intervention will be given specific appointment times/dates.

Enhanced Care

Participants in the enhanced-care intervention will receive free clinic visits, labs, and medications. They will also receive transportation incentives on a sliding scale based on distance to clinic, to range between 200-700 INR to be given each clinic/study visit. All participants, in both the usual care and enhanced care arms, will be offered VL testing free of charge, although this will not be known to the participants prior to the visit.

Enhanced Care
MicroenterpriseBEHAVIORAL

YRG CARE is affiliated with two microenterprise programs in bag-making and food-vending which can be leveraged as part of an intervention, particularly for women. There is an established training and mentoring program for individuals who wish to join the bag-making or food-making ventures. Participants who opt for this will be linked to the bag-making and food-vending programs, with all up-front costs (e.g. vending kiosk, training, serving materials, etc.) covered.

Enhanced Care

Participants in the enhanced-care intervention will participant in an individual enhanced counseling program called Steps to Success, based upon a Life Steps and Problem Solving curriculum. Steps to Success will consist of five one-on-one sessions of approximately 1 to 1.5 hours each. The first session will take place at the time of the participant's second clinical visit to YRG CARE, which will be between 1-3 weeks after the participant is recruited.

Enhanced Care

Usual clinical care and counseling

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult PLHIV presenting to care at YRG CARE who are ART-naïve and who plan to follow-up at YRG CARE
  • Speaks Tamil, Telugu, or English

You may not qualify if:

  • Previous ART exposure
  • Not competent to provide informed consent or participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

YRG CARE

Chennai, Tamil Nadu, 600010, India

Location

MeSH Terms

Conditions

HIV InfectionsAcquired Immunodeficiency Syndrome

Interventions

Appointments and SchedulesFinancial SupportSmall BusinessCounseling

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSlow Virus Diseases

Intervention Hierarchy (Ancestors)

Organization and AdministrationHealth Services AdministrationEconomicsHealth Care Economics and OrganizationsCommerceTechnology, Industry, and AgricultureMental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Physician

Study Record Dates

First Submitted

May 24, 2019

First Posted

May 29, 2019

Study Start

June 20, 2019

Primary Completion

November 18, 2021

Study Completion

December 1, 2023

Last Updated

February 12, 2025

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations